Buspirone
Bucapsol, Buspirone Hydrochloride
NADAC/unit
$0.0216
No Shortage
Tier 1: 287.2%
15 Manufacturers
71 ANDAs
INDICATIONS AND USAGE Buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety.
vs. brand Bucapsol: Generic saves up to 100% per unit
Market Intelligence
2023-11-29 Class III Recall: NCS Healthcare of Kentucky Inc
2023-11-29 Class III Recall: NCS Healthcare of Kentucky Inc
2023-05-03 Class II Recall: Northwind Pharmaceuticals LLC
2023-03-08 Class II Recall: Accord Healthcare, Inc.
2023-03-08 Class II Recall: Accord Healthcare, Inc.
Generic Manufacturers
ACCORD HEALTHCARE INCAIPING PHARMACEUTICAL INCAUROBINDO PHARMA LTDEPIC PHARMA LLCHERITAGE PHARMA LABS INCIMPAX LABORATORIES INCINVENTIA HEALTHCARE PRIVATE LTDMYLAN PHARMACEUTICALS INCOXFORD PHARMACEUTICALS LLCRISING PHARMA HOLDINGS INCRUBICON RESEARCH LTDSTRIDES PHARMA GLOBAL PTE LTDTEVA PHARMACEUTICALS USA INCUNICHEM LABORATORIES LTDZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.